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Original ArticleExercise-induced molecular mechanisms
promoting glycogen supercompensation in
human skeletal muscleJanne R. Hingst 1, Lea Bruhn 1, Mads B. Hansen 1, Marie F. Rosschou 1, Jesper B. Birk 1, Joachim Fentz 1,
Marc Foretz 2,3,4, Benoit Viollet 2,3,4, Kei Sakamoto 5,10, Nils J. Færgeman 6, Jesper F. Havelund 6,
Benjamin L. Parker 7, David E. James 7,8, Bente Kiens 1, Erik A. Richter 1, Jørgen Jensen 1,9,
Jørgen F.P. Wojtaszewski 1,*ABSTRACT
Objective: A single bout of exercise followed by intake of carbohydrates leads to glycogen supercompensation in prior exercised muscle. Our
objective was to illuminate molecular mechanisms underlying this phenomenon in skeletal muscle of man.
Methods: We studied the temporal regulation of glycogen supercompensation in human skeletal muscle during a 5 day recovery period following
a single bout of exercise. Nine healthy men depleted (day 1), normalized (day 2) and supercompensated (day 5) muscle glycogen in one leg while
the contralateral leg served as a resting control. Euglycemic hyperinsulinemic clamps in combination with leg balance technique allowed for
investigating insulin-stimulated leg glucose uptake under these 3 experimental conditions. Cellular signaling in muscle biopsies was investigated
by global proteomic analyses and immunoblotting. We strengthened the validity of proposed molecular effectors by follow-up studies in muscle of
transgenic mice.
Results: Sustained activation of glycogen synthase (GS) and AMPK in combination with elevated expression of proteins determining glucose
uptake capacity were evident in the prior exercised muscle. We hypothesize that these alterations offset the otherwise tight feedback inhibition of
glycogen synthesis and glucose uptake by glycogen. In line with key roles of AMPK and GS seen in the human experiments we observed
abrogated ability for glycogen supercompensation in muscle with inducible AMPK deletion and in muscle carrying a G6P-insensitive form of GS in
muscle.
Conclusion: Our study demonstrates that both AMPK and GS are key regulators of glycogen supercompensation following a single bout of
glycogen-depleting exercise in skeletal muscle of both man and mouse.
 2018 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Exercise; Insulin action1. INTRODUCTION
Glycogen is formed as a branched polymer of glucose serving as an
essential energy depot in times of nutritional surplus that can be readily
mobilized when energy is needed [1]. While liver glycogen directly
contributes to glucose homeostasis by releasing glucose into the
blood, skeletal muscle lacks this ability but accounts for w80% of
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blood glucose levels. The majority of glycogen is stored in skeletal
muscle (a total of w400 g) and the “set-point” for glycogen con-
centration in human skeletal muscle appears to be tightly controlled at
a level of w1.5 g/100 g muscle. This is mediated by an efﬁcient
feedback-regulation of glycogen synthase (GS) by muscle glycogen
concentration [3]. Intriguingly, when a single bout of exercise is fol-
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Figure 1: Study design for one-legged glycogen supercompensation in man. Nine
lean and healthy male subjects underwent a one-legged glycogen supercompensation
regime. Muscle glycogen content was reduced (day 1), normalized (day 2), and
supercompensated (day 5) in one leg while remaining unchanged in the resting control
leg. On average the subjects exercised for 2 1/2 h. Througout the 5 days the subjects
consumed a eucaloric carbohydrate-rich diet. Muscle insulin action was evaluated
under these three different situations by euglycemic hyperinsulinemic clamps (EH
Clamps) and femoral catheterization in combination with measurement of femoral leg
blood ﬂow enabled to calculate insulin-stimulated leg glucose uptake. Muscle biopsies
were obtained from both legs before and after insulin infusion. EH Clamp: Euglycemic
hyperinsulinemic clamp. B: Biopsy from vastus lateralis muscle.synthesis far beyond resting levels (i.e. glycogen supercompensation)
and muscle glycogen concentration can increase up to w4 g/100 g
muscle. In 1966, Bergström and Hultman demonstrated that the ability
to supercompensate muscle glycogen is restricted to the prior exer-
cised muscle [4]. The authors concluded that a single bout of exercise
enhances factors within the prior exercised muscle that were main-
tained for several days after exercise, elevating the “set-point” for
muscle glycogen storage. It is noteworthy that the molecular nature of
these exercise-induced “enhancing factors” that allow for glycogen
synthesis far beyond normalized muscle glycogen concentration re-
mains to be demonstrated.
The activity of glycogen synthase (GS), the key regulatory enzyme in
glycogen synthesis, is controlled by the allosteric activator glucose-6-
phosphate (G6P), and by covalent phosphorylation at inhibiting resi-
dues [5,6]. Insulin enhances glycogen synthesis through increased
glucose uptake and by promoting de-phosphorylation and thus acti-
vation of GS [1,7]. Compared to insulin, exercise results in a more
pronounced de-phosphorylation and hence higher activation of GS in
skeletal muscle [8,9] than during insulin stimulation. A synergy exists
between allosteric and covalent regulation of GS such that GS afﬁnity
for the allosteric activator G6P is enhanced in the de-phosphorylated
state [10,11]. It remains an open question whether this molecular
regulation of GS is involved in the phenomenon of glycogen super-
compensation in skeletal muscle.
AMP activated protein kinase (AMPK) serves as a cellular energy
regulator by monitoring cellular nucleotide status [12]. AMPK binds to
the glycogen particle [13e15] and may also act as a cellular fuel
sensor as muscle glycogen is a negative regulator of AMPK activation
[16,17]. Supporting this concept, prolonged AMPK activation in vivo by
different pharmacological means (e.g. AICAR, PF739 and MK-8722) is
accompanied by elevated muscle glycogen concentration [18e20].
Moreover, missense mutation (gain-of-function) of the AMPK g3 or g1
regulatory subunits is associated with elevated muscle glycogen
content [21e25]. Thus, a tight coupling exists between muscle
glycogen and AMPK. AMPK in human skeletal muscle exists in three
different complexes (a2b2g1, a1b2g1 and a2b2g3) and kinase
activity increases in a trimer-speciﬁc manner during exercise [26e29],
and may stay elevated for several hours into exercise recovery [30].
Studies in rodents suggest that this AMPK activation is necessary for
insulin sensitization of skeletal muscle in the period immediately
following exercise [31,32]. However, whether AMPK is involved in the
regulation of glycogen supercompensation in skeletal muscle remains
to be investigated.
Here, we have used an invasive study in man and advanced muscle
proteomics to revisit the phenomenon of glycogen supercompensation
in skeletal muscle. In the course of 5 days both in vivo physiological
measurements and classical biochemical as well as proteomic ana-
lyses in muscle biopsies revealed temporal regulation of insulin
sensitivity for muscle glucose uptake, intracellular signaling, capacity
for glucose uptake as well as glucose/fatty acid oxidation.
2. METHODS
2.1. One-legged glycogen supercompensation regime in man
The study was approved by the regional ethics committee in Denmark
(Journal number: H-4-2013-071) and performed in accordance with
the Declarations of Helsinki II. Each subject gave written informed
consent before participating. Nine healthy male subjects (age, 26  3
years; BMI, 23.5  1.7 kg/m2; VO2 peak, 45  4 ml O2/min/kg; data
presented as means  SD) underwent a glycogen supercompensation
regime. The study design is illustrated in Figure 1 and a detailedMOLECULAR METABOLISM 16 (2018) 24e34  2018 The Authors. Published by Elsevier GmbH. This is an open ac
www.molecularmetabolism.comdescription of preclinical investigation of the subjects and the experi-
mental design is provided in Supplemental I. The subjects were
familiarized to the one-legged knee extensor model at light intensity
prior to the testing. The working leg was chosen randomly in order to
avoid possible confounding effects of leg dominance. On a separate
day, the peak workload (PWL) of the knee extensors during one-legged
extensor exercise was determined as previously described [33]. On
day 1, the subjects performed one-legged knee extensor exercise until
exhaustion. This exercise protocol consisted of one-legged knee
extensor exercise for 1 h at 80% of PWL interspersed by 5 min bouts at
90% of PWL every 10 min. This was followed by interval exercise until
exhaustion containing 4 min bouts starting at 100% PWL followed by
1 min at 50% of PWL. When the subjects were unable to maintain
kicking frequency during these intervals, the exercise intensity was
lowered by 10% and ﬁnished when the subjects were unable to ﬁnish
4 min at 60% of PWL.
After 4 h of rest, a 120 min euglycemic hyperinsulinemic- (w100 mU/
ml) clamp was performed. This procedure was repeated in the same
subjects in the rested state (without prior exercise) at day 2 and day 5
in order to investigate insulin-stimulated glucose uptake during the
glycogen supercompensation regime. Catheters were inserted in the
femoral veins of both legs and in a heated hand vein for sampling of
arterialized venous blood in order to measure insulin-stimulated
glucose uptake across the legs using A-V balance technique com-
bined with ultrasound Doppler measurements of femoral arterial blood
ﬂow. Muscle biopsies from m. vastus lateralis were obtained before
(basal state) and after 120 min of insulin infusion (insulin-stimulated
state) from both legs at day 1, day 2, and day 5. Throughout the 5 day
supercompensation regime, the subjects consumed a eucaloric diet
composed of 80 E% carbohydrates, 10 E% fat and 10 E% protein.
2.2. Proteomic analyses of human muscle biopsies
Muscle biopsies for proteomic analyses were processed and analyzed
as previously described [34]. A detailed description can be found in
Supplemental I. For MS data repository and the complete data set, see
Supplemental III.cess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 25
Original Article2.3. Muscle processing and western blotting
Homogenates from human muscle biopsies were prepared from
freeze-dried muscle, dissected free of visible fat, blood and connective
tissue. Homogenates from mouse muscle were prepared from wet
muscle. Muscle tissue was subsequently homogenized as described in
detail in Supplemental I. Muscle homogenates and lysates were pre-
pared in sample buffer. Except for GLUT1 and GLUT4 measurements,
all samples were heated for 5 min at 96 C. Equal amounts of sample
were loaded on self-cast gels (7e15%) and separated by SDS-PAGE.
Gels were transferred to polyvinylidene ﬂuoride membranes using
semidry blotting. Membranes were blocked in 2% skim milk or BSA
and subsequently probed overnight at 4 C with primary antibody (see
Supplemental I for full list of primary antibodies). Membranes were
incubated with secondary antibody conjugated with horseradish
peroxidase (HRP) for 45 min at room temperature and protein abun-
dance of phosphorylated proteins and total expression of proteins was
visualized with chemiluminescence (Millipore) and a digital imaging
system (ChemiDoc MP System; Bio-Rad, Copenhagen, DK). Sample
loading and protein transfer were ensured by use of Coomassie-
staining.
2.4. Muscle glycogen content
Muscle glycogen content was measured by a ﬂuorometric method as
glycosyl units after acid hydrolysis on 150 mg homogenates for human
samples and 10e15 mg w.w. muscle for mouse samples [35].
Glycogen content in human muscle homogenates was determined as
average from basal and insulin-stimulated samples as no effect of
insulin was observed.
2.5. Enzyme activity of GS and AMPK
Enzyme activity for GS and AMPK was assayed in muscle homogenate
and lysate, respectively, as speciﬁed in Supplemental I.
2.6. Animal studies
Animal experiments were performed on male mice in compliance with
the European Union convention for protection of vertebra animals used
for scientiﬁc purposes (Council of Europe 123, Strasbourg, France,
1985) and were approved by the Danish Animal Experimental
Inspectorate. Muscle-speciﬁc inducible AMPK a1/a2 double KO mice
(AMPK a imdKO) were generated by use of the Cre/loxP system as
described in detail in Supplemental I. GYS1 KI mice (R582A/R582A)
carrying a G6P-insensitive form of GS in muscle were generated as
previously described [36]. A detailed description of genetic mouse
models and procedures can be found in Supplemental I.
2.7. In vivo glycogen synthesis and in vivo glucose uptake in mice
Animals were restricted from access to chow 2 h prior to the experi-
ments. Mice performed treadmill exercise for 11/2 h at 60% (10%
incline) of maximal running capacity and received oral gavage con-
taining either saline (10 ml/g body wt) (Saline experiment) or glucose
(10 ml/g body wt, 0.2 g/ml glucose) in combination with [3H]-2-
deoxyglucose (2.2 MBq/ml; Perkin Elmer, USA) and [14C]-glucose
(0.74 MBq/ml; Perkin Elmer, USA). Blood samples from the tail vein
were obtained at 0, 20, 40, and 60 min after oral gavage and blood
glucose concentration was monitored by glucometer (Contour XT;
Bayer, Leverkusen, DE). Concurrently, blood plasma was obtained for
determination of 3H and 14C radioactivity. In vivo glycogen synthesis
rate was determined as [14C]-glucose incorporation into glycogen.
Glycogen fraction was puriﬁed by overnight precipitation of muscle
homogenates (10e20 mg muscle boiled in 1 M NaOH for 30 min) in ice
cold (20 C) 96% ethanol in the presence of glycogen (1.14 mg,26 MOLECULAR METABOLISM 16 (2018) 24e34  2018 The Authors. Published by Elsevier GmbH. TSigma, G-8876, DK). After overnight precipitation, samples were
centrifuged (15 min at 3000 g) and washed 3 times in cold ethanol
(20 C); the pellet was suspended in water and counted for 14C
radioactivity by liquid scintillation counting. In vivo glucose uptake was
determined as trapped 2-[3H]-2-deoxyglucose-6-phosphate related to
speciﬁc activity in the blood and the time of exposure as described in
details in Supplemental I.
2.8. Glycogen supercompensation in mouse muscle
Mice were restrained from access to chow 2 h prior to the experiment.
The exercise protocol consisted of 11/2 h treadmill exercise (10%
incline) at 60% of individual maximal running capacity. Glucose gavage
(2 g/kg body wt) was given immediately after exercise and after 1 h of
rest. Five hours after termination of exercise, the mice were killed by
cervical dislocation, and tissues were quickly removed and frozen in
liquid nitrogen. Glucose gavage solution was obtained by dissolving
glucose in saline (0.2 g/ml) and was administered relative to mouse
body weight (10 ml/g body wt).
2.9. Statistical analysis
Data are presented as means  SEM. For the human glycogen
supercompensation regime and in vitro mice studies data are analyzed
by two-way ANOVA with repeated measurements. In vivo experiments
in mice were analyzed by two-way ANOVA. Student-Newman-Keuls
test was used for post hoc testing. A statistical signiﬁcant difference
was accepted for p  0.05
3. RESULTS
3.1. Muscle insulin sensitivity and glucose uptake capacity remain
enhanced in recovery from a single bout of glycogen-depleting
exercise
To investigate the molecular regulation of glycogen super-
compensation, nine male subjects underwent a one-legged glycogen
supercompensation regime. Glycogen content was reduced in muscle
of one leg by one-legged exercise until exhaustion (Exercised Leg) (day
1) (p < 0.001), while the contralateral leg (Rested Leg) served as a
resting control with unchanged glycogen content (p ¼ 0.33)
(Figure 2A). Intake of a carbohydrate-rich, eucaloric diet (80 E% CHO)
in the following days normalized (day 2) and supercompensated
(p < 0.001) (day 5) glycogen content in muscle of the prior exercised
leg while remaining unchanged in muscle from the rested leg
(Figure 2A). Euglycemic-hyperinsulinemic clamps in combination with
catheterization of the femoral veins enabled the measurement of
insulin-action on glucose uptake in the glycogen-depleted muscle in
recovery from exercise (day 1) and under resting conditions with
normalized (day 2) and supercompensated muscle glycogen content
(day 5), respectively. These measurements revealed enhanced insulin-
stimulated glucose uptake across the prior exercised leg compared to
the rested control leg (day 1) (p < 0.001) (Figure 2B). This mechanism
ensures glucose availability for initial glycogen resynthesis in the prior
exercised muscle. Surprisingly, insulin-stimulated glucose uptake in
the rested leg was higher on day 2 and day 5 compared to day 1. This
was associated with higher insulin sensitivity at the whole body level
(GIR) at day 2 and 5 compared to day 1 (Figure 2C). Plasma FFA levels
were markedly enhanced in recovery from exercise and RER values
indicated increased reliance on fat as energy substrate at day 1
compared to day 2 and 5 (Fig S1,S2). Availability of FA has been
indicated as negative regulator of muscle insulin sensitivity and we
speculate that this may be associated with the lowered insulin
sensitivity at a whole body level on day 1. However, as insulin-his is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 2: Muscle glycogen supercompensation in human skeletal muscle involves coordinated upregulation in glucose uptake capacity. Muscle glycogen was depleted
in one leg (day 1), normalized (day 2), and supercompensated (day 5) while remained unchanged in the rested control leg (A). A 120 min euglycemic hyperinsulinemic clamp was
performed to investigate insulin action on glucose uptake 4 h post exercise (day 1) and under resting conditions on day 2 and 5. Insertion of femoral leg catheters in combination
with measurements of leg blood ﬂow allowed for calculation of insulin-stimulated glucose uptake across the prior exercised and rested leg (B). Whole body insulin sensitivity is
given as glucose infusion rate (GIR) during the clamp and presented as AUC for 120 min (mmol/kg body mass) (C). Muscle biopsies were obtained before (basal state) and under
insulin-stimulated conditions (following 120 min insulin infusion). Proteomic analyses was performed on basal biopsies obtained at day 1, 2, and 5 (n ¼ 5). The exercised leg is
presented relative to the rested control leg as log2 ratio. Circle size indicates the magnitude of increase/decrease and signiﬁcant p-value is illustrated by black circles (D). Basal and
insulin-stimulated muscle lysates were investigated for protein expression of GLUT1, GLUT4, HKI, and HKII by use of immunoblotting (EeH). Data are expressed as means  SEM
(n ¼ 8e9). Western blotting data are given as arbitrary units (AU). yp  0.05, yyp  0.01 and yyyp  0.001 for effect of leg. ¤¤p  0.01 and ¤¤¤p  0.001 for signiﬁcant different
from day 1. Main effect is indicated by horizontal line.stimulated glucose uptake was similar in both legs on day 2 and 5
(p ¼ 0.35 and p ¼ 0.15, respectively), enhanced insulin sensitivity
itself seems not to drive glycogen synthesis beyond resting levels (i.e.
glycogen supercompensation).
We next investigated basal skeletal muscle biopsies for key metabolic
proteins by use of proteomic analyses in the rested and exercised leg
on day 1, 2 and 5 (n ¼ 5) (Figure 2D and Supplemental Table S1).MOLECULAR METABOLISM 16 (2018) 24e34  2018 The Authors. Published by Elsevier GmbH. This is an open ac
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glucose transport (GLUT1 and GLUT4) (p < 0.05) and a tendency for
upregulation of proteins involved in glucose phosphorylation (HKI and
HKII) (p-values in the range of 0.07e0.19) while proteins involved in fat
oxidation and glycolysis largely remained unchanged during the
supercompensation period (Figure 2D and Supplemental Table S1). A
single peptide from glycogen synthase 1 isoform 2 (GYS1-2) wascess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 27
Original Articleincreased at day 5 (p ¼ 0.02); however, canonical GYS-1 was not
upregulated, and the maximal activity of GS was not altered
(Supplemental Figs. S3,S4). These observations by proteomics were
strengthened by immunoblotting, revealing a coordinated increase in
the protein expression of HKI, HKII, GLUT1, and GLUT4 (Figure 2EeH
and Fig. S8). Overall, these alterations induced by a single bout of
exercise became apparent the day following exercise (day 2) and
remained throughout the whole glycogen supercompensation regime.
Collectively, these data demonstrate that a single bout of exercise
induces a robust increase in glucose uptake capacity at the level of
glucose transport and phosphorylation. We interpret the temporal order
of these cellular alterations as a mechanism to antagonize the
otherwise negative feedback that glycogen normally exerts on insulin-
stimulated muscle glucose uptake [37,38].
3.2. Muscle AMPK activity is elevated for 5 days following a single
bout of exercise
Given that AMPK contains a glycogen-binding domain and serves as a
cellular fuel-sensor, we evaluated regulation of muscle AMPK
throughout the human glycogen supercompensation regime. A tem-
poral and heterotrimeric-speciﬁc regulation of AMPK activity was
evident in muscle (Figure 3A,B and E). Thus, AMPK a2-containing
complexes were highly activated in recovery from exercise (day 1)
(p < 0.05) and reversed to resting levels the subsequent days (day 2
and 5) (Figure 3AeB). This regulation coincided with enhanced insulin-
stimulated muscle glucose uptake (Figure 2B) and elevated phos-
phorylation at Ser704 and Ser341 of the AMPK downstream targetFigure 3: AMPK trimer-speciﬁc activation in human skeletal muscle during a glyco
a2b2g3 (A), a2b2g1 (B), and a1b2g1 (E) by immunoprecipitation followed by kinase a
phosphorylation at ser221 (F) was investigated in muscle lysate by use of immunoblott
*p  0.05, **p  0.01 and ***p  0.001 for effect of insulin infusion/time. yp  0.05, yy
28 MOLECULAR METABOLISM 16 (2018) 24e34  2018 The Authors. Published by Elsevier GmbH. TTBC1D4 (day 1) (p < 0.001) (Figure 3CeD). In accordance with pre-
vious studies demonstrating that the proximal insulin-signaling
cascade in human muscle remains unaffected by prior exercise
[33,39e41], we observed that Akt phosphorylation at Ser308 and
Thr473 increased similarly in both legs in response to insulin (data not
shown). Given the link between AMPK and insulin sensitivity in rodent
muscle [31,32,42], these ﬁndings support that enhanced a2-AMPK
signaling via distal insulin signaling molecule e TBC1D4 e medi-
ates enhanced insulin sensitivity also in muscle of man.
A selective increase in activity of the AMPK a1-containing complex
was present throughout the 5 days supercompensation regime in
muscle of the exercised leg only (p < 0.05) (Figure 3E). This un-
expected observation was supported by increased phosphorylation
under basal conditions of the well-established AMPK target acetyl-
CoA carboxylase 2 (ACC2) (p < 0.05) (Figure 3F). Given that AMPK
promotes fatty acid oxidation by phosphorylation of ACC2 in the
resting state [43], these observations suggest substrate selection
towards fat oxidation in the prior exercised muscle. Notably, judged
by proteomic analyses, this fuel switch was largely independent of
alterations in expression of proteins involved in fatty acid b-oxida-
tion, glycolysis and glucose oxidation (Supplemental Table S1).
However, we observed that exercise induced phosphorylation
(hence deactivation) of the glucose oxidation-controlling protein
complex pyruvate dehydrogenase (PDH-Ea) on day 1 (Figs. S5e7).
Notably, elevated PDH phosphorylation was still present (p < 0.05)
when glycogen had reversed to resting levels in the prior exercised
muscle on day 2 (Figs. S5e7).gen supercompensation regime. Muscle lysate was investigated for AMPK activity of
ctivity assay. TBC1D4 phosphorylation at ser704 (C) and ser341 (D) as well as ACC
ing with site-speciﬁc antibodies. Data are expressed as means  SEM (n ¼ 8e9).
p  0.01 and yyyp  0.001 for effect of leg. Main effect is indicated by horizontal line.
his is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Collectively, these observations suggest that glycogen super-
compensation involves AMPK-dependent reduced glucose oxidation in
expense of fat oxidation as a cellular mechanism for sustained
glycogen synthesis and hence glycogen supercompensation.
3.3. Acute deletion of AMPK activity in skeletal muscle abrogates
the ability for glycogen supercompensation following exercise
In order to illuminate a necessary role of AMPK in muscle glycogen
supercompensation, we generated a muscle-speciﬁc inducible AMPK
catalytic isoform knock out mouse model (AMPK a1/a2 imdKO). Three
weeks after induction of gene deletion, these mice show marked
deletion of both AMPK a1 and a2 protein expression (Figure 4A). In line
with previous AMPK deﬁcient models, muscle of these mice shows
markedly lower phosphorylation of the AMPK downstream targets
TBC1D1 and ACC (Figure 4A). Importantly, and in contrast to previous
AMPK deﬁcient models, these mice do not suffer from a mitochondrial
phenotype (Figure 4B and Fig. S9). This is highly relevant because 1)
mitochondrial dysfunction may affect substrate utilization and glucose
partitioning toward glycolysis, and 2) muscle of all previous models
used to link AMPK to glycogen storage display mitochondrial
dysfunction [44,45]. Intriguingly, muscle glycogen synthesis in vivo
was markedly reduced in the AMPK imdKO mice (p < 0.05) when
glucose was administered orally following exercise (Figure 4C) even
though muscle glucose uptake in vivo was similar between genotypes
(Figure 4D). As a consequence of the reduced glycogen synthesisFigure 4: Acute muscle-speciﬁc deletion impairs glycogen synthesis following exerc
A novel mouse model with acute genetic deletion of AMPK catalytic activity in skeletal m
signaling of the downstream targets TBC1D1 and ACC was veriﬁed by immunoblotting (A). P
was investigated by use of speciﬁc antibodies (B). In vivo glycogen synthesis rate (C), glucos
from WT mice and mice with acute inducible deletion of AMPK catalytic activity (imdKO). G
glucose gavage (2 g/kg body wt) in the rested state (Rest þ 1 h Glucose) and exercised state
in the basal state and 5 h post exercise with glucose gavage (2 g/kg body wt) given immedia
corresponding resting value. yp  0.005 and yyp  0.01 for effect of genotype. Data are
MOLECULAR METABOLISM 16 (2018) 24e34  2018 The Authors. Published by Elsevier GmbH. This is an open ac
www.molecularmetabolism.comfollowing exercise, the ability to supercompensate muscle glycogen
was abrogated in mice with acutely induced deletion of AMPK catalytic
activity (p < 0.001) (Figure 4E).
In combination with our observations in human muscle, these ﬁndings
suggest that sequential activation of AMPK trimeric complexes in re-
covery from exercise enhances insulin sensitivity to stimulate glucose
uptake and may promote fat oxidation so that intracellular glucose is
directed towards glycogen synthesis even when muscle glycogen has
returned to normal levels. Thus, AMPK is essential for glycogen
supercompensation.
3.4. Glycogen synthase remains in an activated state beyond
normalized muscle glycogen content
Next, we examined whether glycogen supercompensation in human
skeletal muscle was associated with alterations in proteins involved in
the pathway of glycogen synthesis. The formation of new glycogen
particles is initiated by the self-glucosylated enzyme glycogenin. The
observation of unchanged expression of glycogenin-1 (p  0.60) and
other key proteins in glycogen synthesis suggest that glycogen
supercompensation is associated with increased particle size of
existing glycogen granules rather than formation of additional glycogen
particles (Supplemental Table S1).
GS promotes the elongation of glucose chains within the glycogen
particle and is considered as rate-controlling enzyme for glycogen
synthesis [1]. Protein expression of GS remained similar between theise and abrogates the ability for glycogen supercompensation following exercise.
uscle was generated. Deletion of the catalytic subunits AMPK a1 and a2 and reduced
rotein expression of mitochondrial complex proteins (Complex I-V) in quadriceps muscle
e uptake (D) and muscle glycogen concentration (E) were assessed in quadriceps muscle
lycogen synthesis rate and glucose uptake was investigated in vivo in response to oral
(Exercise þ 1 h Glucose). Muscle glycogen content in quadriceps muscle was measured
tely after 11/2 h exercise and again following 1 h recovery.
###p  0.001 for different from
presented as means  SEM (n ¼ 4e8).
cess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 29
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activity of GS was markedly elevated in the prior exercised muscle (day
1) (p < 0.001) and remained elevated the following days (p < 0.01)
even though muscle glycogen content was normalized to resting levels
or supercompensated (Figure 5A). In accordance, phosphorylation of
key inhibitory residues on GS was markedly reduced by exercise (day
1) (p < 0.001) and remained lower the day after exercise (day 2)
(p < 0.05) (Figure 5BeC). Lowered phosphorylation of GS enhances
the sensitivity for allosteric activation by intracellular G6P [11]. Thus
the maintained dephosphorylation by exercise presents a mechanism
for sensitizing GS for allosteric activation by G6P beyond normalized
glycogen content. By using knockin mice (KI) (R582A/R582A) carrying
a G6P-insensitive form of GS in muscle [36], we veriﬁed that allosteric
activation of GS by G6P indeed is essential for glycogen super-
compensation following exercise (Figure 5D). It has previously been
reported that G6P tends to accumulate in muscle of GS KI (R582A/
R582A) compared to WT controls [36]. As G6P accumulation exerts
negative feedback on glucose uptake, we cannot fully exclude that the
absence of glycogen supercompensation in these mice partly arises
from inhibited glucose uptake due to accumulation of G6P. However, in
an additional experiment with saline injection, in which accumulation
of G6P would not be expected, we could demonstrate that in vivo
muscle glucose uptake was similar between genotypes (Figure 5E).Figure 5: Muscle glycogen supercompensation in man reveals sustained activatio
Enzyme-activity of GS was determined in muscle homogenates as fractional activity (activit
key regulatory sites 3aþ3 b and 2þ2a was measured by immunoblotting (BeC). Glycoge
muscle (R582A/R582A) was measured under basal conditions (Basal) and 5 h following e
exercise (D). In vivo glucose uptake (E) and in vivo glycogen synthesis (F) in quadriceps mu
saline) and prior exercised state (Exercise þ 1 h saline) by oral gavage of saline contai
(n ¼ 8e9 for AeC and n ¼ 6e8 for DeE). *p  0.01 and ***p  0.001 for effect of insuli
human experiment and for effect of genotype in mice experiment. #p  0.05 and ###p 
horizontal line.
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glycogen synthesis rate in WT mice but not in GS KI (R582A/R582A)
mice (Figure 5F), demonstrating that muscle glycogen synthesis
following exercise is fully dependent on allosteric regulation of GS.
Because GS is rate-limiting for glycogen synthesis from intracellular
glucose, the above described alterations on GS regulation in man will
indeed favor glycogen storage in the prior exercised muscle.
4. DISCUSSION
Based on our observations, we propose the following model of mo-
lecular mechanisms induced by exercise enhancing glycogen storage
in human skeletal muscle: The cellular fuel-sensor AMPK a2 is
activated by a single bout of glycogen-depleting exercise and remains
activated into the immediate recovery period. This provides an insulin
sensitizing effect on insulin-stimulated glucose uptake in the prior
exercised muscle and secures adequate glucose supply for glycogen
re-synthesis. Moreover, we suggest that the prolonged activation of
AMPK a1 following exercise promotes glucose sparing for glycogen
synthesis in expense of fat oxidation. These alterations lead to high
cellular glucose availability in the exercised muscle, and the ﬁnal
partitioning towards glycogen is secured as the rate limiting enzyme -
GS - remains activated and insulin responsive even when glycogenn of glycogen synthase (GS) far beyond normalized muscle glycogen content.
y in the presence of 0.17 mM G6P relative to 8 mM G6P) (A). GS phosphorylation at the
n content in quadriceps muscle from mice expressing a G6P-insensitive form of GS in
xercise where glucose gavage (2 g/kg body wt) was given immediately and 1 h post
scle from WT and R582A/R582A mice was determined in the rested state (Rest þ 1 h
ning [14C]- Glucose and [3H]-2-deoxyglucose. Data are expressed as means  SEM
n infusion/time. (y) p  0.1, yp  0.05, yyp  0.01 and yyyp  0.001 for effect of leg in
for signiﬁcantly different from corresponding resting value. Main effect is indicated by
his is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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content is normalized or supercompensated. Collectively, these
cellular alterations provide a potential mechanism to offset the
otherwise tight inhibitory effect that glycogen exerts on glucose up-
take and glycogen synthesis [37,46], hereby allowing for muscle
glycogen supercompensation.
The supercompensated glycogen level reported by Bergström and
Hultman was w35% higher compared to the one observed in the
current study (890 vs. 660 mmol/g dw muscle). It has previously been
demonstrated that the timing of carbohydrates following exercise is
essential for obtaining maximal glycogen synthesis [47]. In order to
determine insulin sensitivity at a time-point where glucose uptake and
leg blood ﬂow were normalized, the current study involved a period of
6 h (4 h rest post exercise and 2 h euglycemic hyperinsulinemic clamp)
before carbohydrates were provided to the subjects on day 1. Although
not fully clear from their paper, we ﬁnd it unlikely that intake of car-
bohydrate in the Bergström and Hultman study should have been
delayed by 6 h. This difference in study design may offer some ex-
planations to the difference in maximal obtainable glycogen levels
between these two studies.
Proteomic analyses in combination with immunoblotting revealed that
a single exercise bout resulted in a marked upregulation in proteins
involved in muscle glucose uptake (GLUT1, GLUT4, HKI, and HKII) in the
prior exercised muscle, while expression of key metabolic proteins in
glycogen synthesis, glycolysis and fatty acid b oxidation remained
unchanged. Indeed, glucose uptake in the prior exercised leg in the
supercompensated state was similar to the resting leg within normal
glycogen content. We hypothesize that increased expression of pro-
teins involved in glucose uptake may be necessary to maintain glucose
uptake when muscle glycogen is supercompensated. Supporting this
concept, increased protein expression of GLUT4 and hexokinase in rat
and human muscle has been reported w3e16 h following a single
exercise bout [48e50]. High glycogen is a known negative regulator of
glucose uptake and glycogen synthesis in both basal and insulin-
stimulated conditions [46]. However, this phenomenon is offset in
the conditions during glycogen supercompensation as evident from the
equal basal as well as the similar increase in insulin-stimulated
glucose uptake on day 2 and 5 in the prior exercised compared to
rested muscles. We propose that the elevated expression of proteins
determining glucose uptake capacity (GLUT1, GLUT4, HKI, and HKII)
provide a mechanism to antagonize the otherwise negative feedback
glycogen exerts on insulin-stimulated glucose uptake. This may be
essential during hyperglycemic conditions repeatedly experienced
during the carbohydrate loading as part of the glycogen super-
compensation regime. In line, hyperglycemia together with hyper-
insulinemia achieved by prolonged infusion (8 h) forces glucose uptake
even when muscle glycogen levels are normal [51]. Under these
conditions GS regulation becomes crucial for the partitioning of glucose
towards glycogen storage. The activity of GS was markedly elevated
following exercise and remained elevated even at day 2 and 5. At day
2, this coincided with sustained dephosphorylation of GS. These
modulations enhance the afﬁnity for the substrate UDP-glucose and
the afﬁnity for G6P binding (i.e. potential allosteric activation of GS) and
thus secure optimal conditions for GS function [10,11]. Intriguingly,
whereas the basal GS activity was similar in muscle of the two legs on
day 5, insulin’s ability to activate GS was on average 38% higher in the
prior exercised muscle. These modulations signify that the covalent
regulation of the G6P-binding afﬁnity is a potential important regulatory
mechanism for glycogen supercompensation. Our observation in
mouse muscle expressing the G6P-insensitive GS mutant indeed
supports such a view. The functional outcome of these alterations is a
condition allowing prior exercised muscle to maintain a high rate ofMOLECULAR METABOLISM 16 (2018) 24e34  2018 The Authors. Published by Elsevier GmbH. This is an open ac
www.molecularmetabolism.comglycogen synthesis, even in the face of normalized or elevated
glycogen content, ultimately leading to glycogen supercompensation.
The maintained activation of all AMPK-complexes in recovery from
exercise (day 1) coincided with increased insulin-stimulated glucose
uptake in the prior exercised muscle as well as increased regulatory
phosphorylation of TBC1D4. We interpret this signaling convergence of
AMPK and TBC1D4 on day 1 as a physiological mechanism that pro-
vides glucose uptake for the highly prioritized glycogen synthesis in the
early recovery period from exercise. This interpretation is supported by
genetic evidence in mouse muscle where the insulin sensitizing effect
of prior AMPK activation by AICAR and exercise is dependent on intact
AMPK a2 activity and correlated to TBC1D4 phosphorylation [31,32]. In
line, in human muscle, we observed that the disappearance of the
insulin-sensitizing effect of prior exercise coincided with the loss of
elevated AMPK a2 activity on day 2 and 5. Thus, these observations
provide a plausible mechanism for the immediate return of glycogen to
resting level but they do not provide a mechanism for glycogen syn-
thesis beyond that point.
Notably, insulin-stimulated glucose uptake in the rested leg was found
to be lower at day 1 compared to day 2 and 5. This observations
coincides with elevated plasma FA levels and substrate selection (RER)
towards fat oxidation on day 1 compared to day 2 and 5. We speculate
that this increase in circulating levels of FA in fasting recovery from
glycogen-depleting exercise (day 1) exerts a dampening effect on
whole body insulin sensitivity. From a physiological point of view,
dampening the sensitivity in non-exercised muscle while maintaining
the sensitivity near normal or above in the exercised muscles would
help sparring glucose for storage and indeed help reload the glycogen
storage in the prior exercised muscle. As our study design does not
allow for a ﬁnal conclusion on this matter (due to the lack of
randomization of experimental days/diet), further studies are war-
ranted to study the isolated effect of prolonged exercise on whole body
insulin sensitivity.
The observation of sustained AMPK a1 activity and phosphorylation of
the fat oxidation promoting enzyme ACC and phosphorylation of the
inhibitory site 1 and 2 on PDH in the present study provide a cellular
mechanism in skeletal muscle that directs intracellular glucose to-
wards glycogen synthesis in a situation in which increased glucose
oxidation would be expected. This molecular mechanism could explain
previous observations of substantially increased fat oxidation in the
post exercise period, an effect that can last for several hours or even
days after cessation of exercise [52e56]. Notably, elevated fat
oxidation in exercise recovery is even seen when dietary intake of
carbohydrates is increased [52,55,56], a situation in which high car-
bohydrate oxidation otherwise would be expected.
Previous studies have reported that AMPK is involved in regulation of
muscle glycogen content without providing underlying mechanisms.
For example, chronic activation of AMPK by missense mutation of
AMPK g3 or g1 leads to excessive accumulation of muscle glycogen
[21e25]. In line, deletion of either AMPK g3 or functional AMPK a2 is
associated with reduced glycogen storage following exercise
[21,57,58]. The essential role of AMPK in glycogen supercompensation
seen in the present study adds signiﬁcantly to this view, because the
AMPK ablation was induced acutely allowing the resulting phenotype to
be under minimal if any inﬂuence by secondary cellular compensation
(e.g. mitochondrial dysfunction as seen in all other of the above
mentioned AMPK deﬁcient models). In the transgenic mouse model
used in the current study, both catalytic subunits were deleted acutely
in skeletal muscle. Accordingly, this does not allow for investigating the
relative contribution of AMPK a1 and a2 in the regulation of glycogen
supercompensation. Genetic deletion of both isoforms was chosen ascess article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 31
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have resulted in a compensatory increase abundance of the remaining
isoform [59], complicating the overall physiological interpretation to the
role of AMPK.
5. CONCLUSION
To conclude, a single bout of exercise induces temporal cellular al-
terations potentially offsetting the otherwise tight feedback inhibition of
glycogen synthesis and glucose uptake by glycogen, ultimately
allowing muscle glycogen to become supercompensated in the post
exercise period.
The potential translational value of these mechanistic insights should be
appreciated considering the outmost importance of pre-competition
muscle glycogen content for endurance exercise performance [60] e
driving athletes to seek optimal glycogen supercompensation regimes
in preparation for competition. Furthermore, impaired insulin-stimulated
glycogen synthesis is a hallmark in muscle insulin resistance as
observed in various diseased conditions like type 2 diabetes [61], and
the present ﬁndings may indeed be applicable in therapeutic strategies.
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